Prognosis for metastatic sarcoma is absymal. Any improvement in this even by a few months is a big deal and will be quickly endorsed by FDA. A very strategic decision, kudos to Nox.
- Forums
- ASX - By Stock
- Ann: Veyonda FDA Approved Trial to Commence
Prognosis for metastatic sarcoma is absymal. Any improvement in...
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.45M |
Open | High | Low | Value | Volume |
7.0¢ | 7.0¢ | 7.0¢ | $2.863K | 40.90K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 141114 | 6.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 4493 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 141114 | 0.066 |
1 | 100000 | 0.064 |
1 | 77000 | 0.062 |
2 | 31393 | 0.061 |
3 | 103300 | 0.060 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 4493 | 1 |
0.075 | 44998 | 2 |
0.079 | 10000 | 1 |
0.081 | 12345 | 1 |
0.083 | 40000 | 1 |
Last trade - 10.21am 20/06/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online